Key Highlights
- Coty (NYSE:COTY) lifted reported Net Income to USD 106.2 million from USD 64.6 million, a 64% gain, even though net Revenue slipped 1% to USD 1,555.2 million.
- e.l.f. Beauty (NYSE:ELF) grew net sales 51% to USD 520.8 million, but GAAP diluted EPS was USD 0.50 against adjusted EPS of USD 1.21.
- Interparfums (NASDAQ:IPAR) held net sales flat at USD 429.5 million while Operating Margin rose to 27.4% from 25.3%.
- Nature's Sunshine Products (NASDAQ:NATR) saw China net sales fall 48.8%, and total third quarter net sales dropped 9.1% to USD 116.6 million.
Coty (NYSE:COTY): Profit Up 64% on an Equity Swap Swing
Coty (NYSE:COTY) reported first quarter fiscal 2027 results on November 4, 2026. Net revenue was USD 1,555.2 million, down 1% reported and 2% like-for-like. Reported net income attributable to common shareholders rose to USD 106.2 million from USD 64.6 million, about 64.4% (calculated), while adjusted net income was USD 146.1 million versus USD 106.0 million. A USD 14.8 million mark-to-market gain on an equity swap, against a USD 26.5 million negative effect a year earlier, explains much of the gain, because reported Operating Income fell to USD 170.4 million from USD 185.0 million. Adjusted EBITDA fell 7% to USD 274.2 million, and adjusted gross margin eased 120 basis points to 63.3% on freight, material and obsolescence costs. Free Cash Flow rose to USD 84.6 million from USD 11.2 million, and financial net Debt fell to USD 2,576.4 million. The group sells fragrances, cosmetics and nail products, and it calls fiscal 2027 a transition year ahead of a strategic review due by the end of calendar 2026. For the second quarter it expects adjusted EPS excluding the swap of USD 0.16 to USD 0.18.
e.l.f. Beauty (NYSE:ELF): 51% Sales Growth, USD 0.50 GAAP EPS
e.l.f. Beauty (NYSE:ELF) announced second quarter fiscal 2027 results on November 4, 2026. Net sales rose 51% to USD 520.8 million, the 31st consecutive quarter of growth, yet GAAP diluted EPS was USD 0.50 on net income of USD 30.0 million. The company sells cosmetics, skincare and hair products under brands including e.l.f. Cosmetics, rhode, Naturium and Well People. SG&A rose USD 69.0 million to USD 300.1 million, about 57.6% of net sales (calculated), and a USD 17.7 million Fair Value charge on the rhode earnout also weighed. The USD 42.7 million gap between GAAP and adjusted net income is calculated from the release, which gives no prior-year net income. Gross margin rose about 160 basis points to 71%, with roughly 30 basis points from IEEPA Tariff refunds, and for six months the refunds added about 520 basis points to a 77% margin. Fiscal 2027 net sales growth guidance rose to 22% to 24% from 18% to 20%, with adjusted EPS now USD 3.82 to USD 3.86. Cash was USD 350.8 million against total debt of USD 826.7 million, compared with USD 194.4 million and USD 856.7 million a year earlier. Adjusted figures exclude stock-based compensation, earnout changes and acquired-intangible amortization.
Interparfums (NASDAQ:IPAR): 27.4% Operating Margin on Flat Sales
Interparfums (NASDAQ:IPAR) filed its third quarter 10-Q on November 4, 2026. Net sales were USD 429.5 million, essentially flat against USD 429.6 million a year earlier, as European based sales rose 4% to USD 305.9 million and United States based sales fell to USD 127.3 million. Management tied the United States weakness to Supply chain disruption that pushed about USD 10 million of giftset shipments into the fourth quarter. The company designs and sells prestige fragrances mainly under licenses including Jimmy Choo, Coach, Montblanc and GUESS. Diluted EPS rose to USD 2.13 from USD 2.05, and gross margin of 67.1% compared with 63.5%, helped by mix, lower destruction costs and USD 14.8 million of tariff refunds that the filing treats as a non-recurring cut to cost of sales. Management plans to reinvest the refunds in promotion, with full-year spending near 21% of net sales. Over nine months, sales rose 1% to USD 1,115.4 million. The company drew euro 55.0 million of a euro 200 million Facility to fund its share repurchase program, and the filing gives no formal guidance.
Nature's Sunshine Products (NASDAQ:NATR): China Sales Fall 48.8%
Nature's Sunshine Products (NASDAQ:NATR) filed its Quarterly Report on November 4, 2026. The company sells over 800 health and wellness products through independent consultants. Third quarter net sales fell 9.1% to USD 116.6 million, with Asia down 14.9% to USD 55.1 million. China sales dropped 48.8%, or USD 5.5 million, which the filing attributes to the passing of two key leaders and corrective actions involving consultants. Diluted EPS was USD 0.11 against USD 0.30, and operating income fell 41.1% to USD 5.3 million. The effective tax rate rose to 64.8% from 42.8%. Cash was USD 89.4 million with no Credit facility balance, but USD 76.1 million sat in foreign markets and may face Withholding taxes or repatriation limits. A voluntary self-disclosure to the Office of Foreign Assets Control is pending, with potential violations estimated below 1% of net revenue in each of the last three fiscal years. The filing gives no guidance.
Where Things Stand
Coty's profit rose mainly because of a non-operating swap gain, not stronger trading, and the other three names show how different beauty and wellness results can look. Coty (NYSE:COTY) saw operating income and adjusted EBITDA fall. e.l.f. Beauty (NYSE:ELF) grew sales 51% but GAAP profit lagged adjusted profit. Interparfums (NASDAQ:IPAR) leaned on margin and one-off refunds, with flat sales. Nature's Sunshine Products (NASDAQ:NATR) is exposed to China, where sales halved and the filing gives no guidance. None of the four filings supplies a share price reaction or consensus comparison, so this is a read of reported figures only. Next markers are are Coty's strategic review, e.l.f. fiscal third quarter sales, the Interparfums holiday quarter and the pending OFAC matter.


_11_20_2026_14_55_23_118425.jpg)



Please wait processing your request...